Medtronic will acquire CathWorks for up to $585 million in a move to expand its interventional cardiology portfolio. The deal follows a 2022 strategic partnership and co-promotion agreement between the two companies for CathWorks’ noninvasive technology that uses AI and…
Supply Chain
The FDA has approved a new class of ablation device — Abbott’s Volt pulsed field ablation system — for the treatment of atrial fibrillation. The Volt system delivers high-energy electrical pulses to targeted areas of the heart to disrupt abnormal…
Medtronic has recalled certain DLP Left Heart Vent Catheters due to a defect that could cause serious injury or death. The recall applies to model numbers 12110, 12113 and 12115 with UDI-DIs 20643169880676, 20643169881338 and 20643169880935, according to a Dec.…
An FDA advisory panel declined to endorse the Ventura interatrial shunt system, a heart failure device developed by V-Wave, a Johnson & Johnson company, according to a Dec. 5 TCTMD report. Panel members cited a lack of demonstrated benefit and…